AllAnalyst Report
logoArgusJune 22, 2021

Integra LifeSciences Holdings Corporation: Reaffirming BUY and $90 target

Symbols
IART
Sector(s)
Healthcare
Rating
Current Price
$28.41
Price Target
Earnings Estimate
Summary

Based in Plainsboro, New Jersey, Integra is an integrated medical device company that develops and markets devices for use in neurosurgery, wound repair, and the orthopedic reconstruction of joints in extremities such as shoulders, wrists, ankles and feet. The company's products are used in cranial and spinal procedures, peripheral nerve repair, repair of skin and deeper tissue from burns and vehicular accidents, and the repair and reconstruction of soft tissue. It operates in two segments: Codman

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade

Analyst Profile

David H. Toung

Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.